Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

ABSTRACT:

SUBMITTER: Bowyer S 

PROVIDER: S-EPMC5396114 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature